HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T K Sawyer Selected Research

AP22161

3/2000A Src SH2 selective binding compound inhibits osteoclast-mediated resorption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T K Sawyer Research Topics

Disease

3Neoplasms (Cancer)
09/2006 - 05/2005
1Colorectal Neoplasms (Colorectal Cancer)
06/2006
1Bone Diseases (Bone Disease)
05/2005
1Osteoporosis
03/2000
1Osteopetrosis
03/2000

Drug/Important Bio-Agent (IBA)

2src-Family KinasesIBA
06/2006 - 03/2000
1CalpainIBA
09/2006
1Peptide Hydrolases (Proteases)FDA Link
09/2006
1Matrix Metalloproteinases (MMPs)IBA
09/2006
1IntegrinsIBA
09/2006
1CytokinesIBA
06/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2006
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
06/2006
1Proteins (Proteins, Gene)FDA Link
05/2005
1EnzymesIBA
05/2005
1AP22161IBA
03/2000